0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
Letter to the Editor   |    
Meige’s Syndrome Associated With Risperidone Therapy
JAMBUR ANANTH, M.D.; KARL BURGOYNE, M.D.; SANDRA AQUINO, M.D.
Am J Psychiatry 2000;157:149-149.

To the Editor: Risperidone is an atypical antipsychotic that is effective for the positive, negative, and cognitive symptomsof schizophrenia (1). The incidence of extrapyramidal signs has been reported to be low during treatment with a dose of 6 mg/day. We report a case of Meige’s disease (24), an extrapyramidal syndrome that was secondary to risperidone treatment.

Mr. A was a 43-year-old, single Caucasian male who became psychiatrically ill at age 22 years and had since been taking various neuroleptics. From 1980 to 1996, he was prescribed thioridazine, 50 mg/day. More recently, his thioridazine therapy was changed to treatment with risperidone, 6 mg/day, as a result of an exacerbation of his symptoms. Mr. A then started blinking frequently. Sometime later, he noted episodic blepharospasms that either occurred spontaneously or were triggered by stress. As a result, he had to discontinue vision-dependent activities such as driving. More recently, he sought help for blepharospasms.

During an interview, Mr. A was noted to have intermittent blepharospasms that affected his vision. The more he tried to open his eyes, the more tightly his eyelids closed. He often struggled for about 3–5 minutes to open his eyes.

This patient had Meige’s disease that was secondary to his risperidone treatment. Because dopamine-2 blocking agents such as neuroleptics have been known to cause Meige’s disease (5), this finding is not surprising. In this case, tardive dystonia was ruled out because he had no other evidence of choreoathetotic movements elsewhere in his body. Spontaneous Meige’s disease was ruled out because of the absence of a family history of Parkinson’s disease, abnormal facial movements, and concomitant physical illnesses such as multiple sclerosis or autoimmune disorders. It is important to recognize this condition because the withdrawal of antipsychotic drugs may lead to a complete recovery from Meige’s disease.

Marder SR, Meibach RC: Risperidone in the treatment of schizophrenia. Am J Psychiatry  1994; 151:825–835
[PubMed]
 
Meige H: Les convulsions de la face, une forme clinique de convulsion faciale, bilaterale et mediane. Rev Neurol (Paris)  1910; 20:437–443
 
Faulstich ME, Carnicke CLM, Williamson DA: Blepharospasm and Meige’s syndrome: a review of diagnostic, etiologic and treatment approaches. J Psychosom Res  1985; 29:89–94
[PubMed]
[CrossRef]
 
Jankovic J, Ford J: Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol  1983; 13:402–411
[PubMed]
[CrossRef]
 
Ananth J, Edelmuth E, Dargan B: Meige’s syndrome associated with neuroleptic treatment. Am J Psychiatry  1988; 145:513–515
[PubMed]
 
+

References

Marder SR, Meibach RC: Risperidone in the treatment of schizophrenia. Am J Psychiatry  1994; 151:825–835
[PubMed]
 
Meige H: Les convulsions de la face, une forme clinique de convulsion faciale, bilaterale et mediane. Rev Neurol (Paris)  1910; 20:437–443
 
Faulstich ME, Carnicke CLM, Williamson DA: Blepharospasm and Meige’s syndrome: a review of diagnostic, etiologic and treatment approaches. J Psychosom Res  1985; 29:89–94
[PubMed]
[CrossRef]
 
Jankovic J, Ford J: Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol  1983; 13:402–411
[PubMed]
[CrossRef]
 
Ananth J, Edelmuth E, Dargan B: Meige’s syndrome associated with neuroleptic treatment. Am J Psychiatry  1988; 145:513–515
[PubMed]
 
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Web of Science® Times Cited: 10

Related Content
Books
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 4.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 12.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 12.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 26.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 26.  >
Topic Collections
Psychiatric News
Read more at Psychiatric News >>
PubMed Articles